OrthoPediatrics Corp.
KIDSNASDAQHealthcare● Active
$18.24
$-0.08(-0.41%)
Market Cap$468615120
P/E Ratio—
52W High$23.7
52W Low$14.42
OrthoPediatrics Corp. (KIDS) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
KIDS · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 30, 2026EPS Actual
-$0.42
Est. -$0.38 · -10.5%
Revenue
$0.06B
Est. $0.06B · +1.9%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 30, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
KIDS reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.00B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.00B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 4, 2026 | -$0.31 | — | — | — | $0.07B | — |
| ▼ Q2 FY2026 | Apr 30, 2026 | -$0.38 | -$0.42 | -10.5% | $0.06B | $0.06B | +1.9% |
| ▲ Q1 FY2026 | Feb 26, 2026 | -$0.37 | -$0.26 | +29.7% | $0.06B | $0.06B | +2.4% |
| ▲ Q4 FY2025 | Oct 28, 2025 | -$0.26 | -$0.24 | +7.7% | $0.06B | $0.06B | +3.3% |
| ▲ Q3 FY2025 | Aug 5, 2025 | -$0.17 | -$0.11 | +35.3% | $0.06B | $0.06B | -0.5% |
| ▼ Q2 FY2025 | May 7, 2025 | -$0.26 | -$0.39 | -50.0% | $0.05B | $0.05B | +1.4% |
| ▲ Q1 FY2025 | Mar 4, 2025 | -$0.33 | -$0.29 | +12.1% | $0.05B | $0.05B | -0.6% |
| ▼ Q4 FY2024 | Nov 6, 2024 | -$0.12 | -$0.18 | -50.0% | $0.05B | $0.05B | +7.6% |
Q3 FY2026
Aug 4, 2026
EPS Actual
—
EPS Est.
-$0.31
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 30, 2026Miss
EPS Actual
-$0.42
EPS Est.
-$0.38
EPS Surpr.
-10.5%
Revenue
$0.06B
Q1 FY2026
Feb 26, 2026Beat
EPS Actual
-$0.26
EPS Est.
-$0.37
EPS Surpr.
+29.7%
Revenue
$0.06B
Q4 FY2025
Oct 28, 2025Beat
EPS Actual
-$0.24
EPS Est.
-$0.26
EPS Surpr.
+7.7%
Revenue
$0.06B
Q3 FY2025
Aug 5, 2025Beat
EPS Actual
-$0.11
EPS Est.
-$0.17
EPS Surpr.
+35.3%
Revenue
$0.06B
Q2 FY2025
May 7, 2025Miss
EPS Actual
-$0.39
EPS Est.
-$0.26
EPS Surpr.
-50.0%
Revenue
$0.05B
Q1 FY2025
Mar 4, 2025Beat
EPS Actual
-$0.29
EPS Est.
-$0.33
EPS Surpr.
+12.1%
Revenue
$0.05B
Q4 FY2024
Nov 6, 2024Miss
EPS Actual
-$0.18
EPS Est.
-$0.12
EPS Surpr.
-50.0%
Revenue
$0.05B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.13 | $0.13 | $0.14 | 1 |
| Q3 FY2028 | $0.29 | $0.29 | $0.30 | 1 |
| Q2 FY2028 | $0.02 | $0.02 | $0.02 | 1 |
| Q1 FY2028 | $-0.34 | $-0.34 | $-0.34 | 1 |
| Q4 FY2027 | $-0.18 | $-0.18 | $-0.18 | 1 |
| Q3 FY2027 | $-0.13 | $-0.13 | $-0.12 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2028 | $0.1B | $0.1B | $0.1B | 1 |
| Q2 FY2028 | $0.1B | $0.1B | $0.1B | 1 |
| Q1 FY2028 | $0.1B | $0.1B | $0.1B | 1 |
| Q4 FY2027 | $0.1B | $0.1B | $0.1B | 2 |
| Q3 FY2027 | $0.1B | $0.1B | $0.1B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | Apr 30, 2026 | -10.5% | $14.64 | $15.06 | +2.87% |
| ▲ Q1 FY2026 | Feb 26, 2026 | +29.7% | $16.72 | $17.79 | +6.40% |
| ▲ Q4 FY2025 | Oct 28, 2025 | +7.7% | $16.96 | $16.91 | -0.29% |
| ▲ Q3 FY2025 | Aug 5, 2025 | +35.3% | $20.53 | $20.19 | -1.66% |
| ▼ Q2 FY2025 | May 7, 2025 | -50.0% | $21.40 | $22.18 | +3.64% |
| ▲ Q1 FY2025 | Mar 4, 2025 | +12.1% | $23.15 | $22.89 | -1.12% |
| ▼ Q4 FY2024 | Nov 6, 2024 | -50.0% | $29.81 | $30.95 | +3.82% |
| ▲ Q3 FY2024 | Aug 5, 2024 | +25.8% | $29.56 | $29.04 | -1.76% |
Q2 FY2026+2.87%
Report Date
Apr 30, 2026
EPS Beat/Miss
-10.5%
Price Before
$14.64
Price After
$15.06
Q1 FY2026+6.40%
Report Date
Feb 26, 2026
EPS Beat/Miss
+29.7%
Price Before
$16.72
Price After
$17.79
Q4 FY2025-0.29%
Report Date
Oct 28, 2025
EPS Beat/Miss
+7.7%
Price Before
$16.96
Price After
$16.91
Q3 FY2025-1.66%
Report Date
Aug 5, 2025
EPS Beat/Miss
+35.3%
Price Before
$20.53
Price After
$20.19
Q2 FY2025+3.64%
Report Date
May 7, 2025
EPS Beat/Miss
-50.0%
Price Before
$21.40
Price After
$22.18
Q1 FY2025-1.12%
Report Date
Mar 4, 2025
EPS Beat/Miss
+12.1%
Price Before
$23.15
Price After
$22.89
Q4 FY2024+3.82%
Report Date
Nov 6, 2024
EPS Beat/Miss
-50.0%
Price Before
$29.81
Price After
$30.95
Q3 FY2024-1.76%
Report Date
Aug 5, 2024
EPS Beat/Miss
+25.8%
Price Before
$29.56
Price After
$29.04
Avg Beat Reaction+0.31%
Avg Miss Reaction+3.44%
Beat Rate5 / 8 quarters
Largest Move+6.40% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: KIDS ends December
OrthoPediatrics Corp. (KIDS) most recently reported earnings on April 30, 2026 for Q2 FY2026, posting EPS of $-0.42 — missing the analyst consensus of $-0.38 by -10.5%. The next KIDS earnings date is expected around September 1, 2026.
Each quarter, investors track KIDS earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. KIDS revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
KIDS's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
KIDS earnings · 5 questionsOrthoPediatrics Corp.'s next earnings report is expected around September 1, 2026. KIDS typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; KIDS historically reports after market close (AMC).
KIDS earnings datewhen is KIDS earningsKIDS next earnings datewhen does KIDS report earningsKIDS earnings calendar
▸ Source: FMP · OrthoPediatrics Corp. SEC filings · US GAAP · OrthoPediatrics Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026